Sign in

CIK 0001810182

  • Non-accelerated filer
  • Smaller reporting company

ALX ONCOLOGY HOLDINGS INC

Sign in to watch
Ticker
ALXO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
850642577
Phone
+1 650-466-7125
Business address
323 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-06-11 Graham G. Walmsley Director Grant or award · Stock option (right to buy) +12,004 12,004
2020-12-14 Graham G. Walmsley Director Purchase +20,000 $76.00 $1.5M 995,000
2020-07-21 Graham G. Walmsley Director Conversion +2,105,901 2,161,981
2020-07-21 Graham G. Walmsley Director Purchase +975,000 $19.00 $18.5M 975,000
2020-07-21 Graham G. Walmsley Director Conversion · Series C Convertible Preferred Stock −2,105,901 0
2020-07-16 Graham G. Walmsley Director Grant or award · Stock Option (right to buy) +24,009 24,009

Page 1 of 1 · 6 trades